April 22, 2015

If you were impressed by the recent switches of Nasacort Allergy 24HR, Nexium 24HR or Flonase — well-executed and model switches — well, you ain’t seen nothing yet.

April 20, 2015

DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.

April 13, 2015

The Food and Drug Administration on Monday cleared InControl Medical's urinary incontinence device for sale OTC. 

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

February 4, 2015

DSN examines chain pharmacy, including in-depth coverage of telehealth, generic drug prices, and the GPhA CEO to step down, as well as Uhl appointed director of OGD, in this multi-page report.

February 3, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the cough-cold categories, highlighting new products that are transforming OTC in this multi-page report.

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

January 5, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the vitamins, minerals and supplements and diet aid categories, highlighting new products that are transforming OTC in this multi-page report.

December 12, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.

December 5, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics, vitamins, allergy/cold/sinus medications, and incontinence, highlighting new products that are transforming OTC in this multi-page report.

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.

November 13, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in blood-pressure monitoring kits and blood-glucose meters, highlighting new products that are transforming OTC in this multi-page report.

October 10, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, in this multi-page report.

October 10, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics and digestives, highlighting new products that are transforming OTC in this multi-page report.

September 16, 2014

DSN examines chain pharmacy, including in-depth coverage of Hispanic consumers and in-store testing, in this multi-page report.

September 16, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in homeopathy and foot care, highlighting new products that are transforming OTC in this multi-page report.

August 20, 2014

Adult incontinence and urinary bladder control represent one of the more lucrative categories in OTC, but it’s not necessarily the most talked-about category.

August 20, 2014

Merck Consumer Care’s Oxytrol for Women brings women with overactive bladder concerns to the self-care aisle for the first time.

August 19, 2014

Nearly half of women age 45 years or older who experience symptoms of overactive bladder report their current treatment does not address their OAB symptoms, according to a recent survey conducted by The Harris Poll on behalf of Allergan.

August 18, 2014

DSN examines chain pharmacy, including in-depth coverage of generics and technology, in this multi-page report.

August 18, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in pain, cough-cold, overactive bladder, allergy and more, highlighting new products that are transforming OTC in this multi-page report.

January 7, 2014

Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.

September 26, 2013

Merck Consumer Care announced that Oxytrol for Women is now on shelf for the more than 20 million women suffering from overactive bladder.

August 8, 2013

The big news in incontinence is Oxytrol, which doesn't reach store shelves until September. It's a switched product coming from Merck Consumer Care that brings an entirely new indication to the over-the-counter space — overactive bladder in women.